Evidence map›Paper›PMID 33349665›Full record

ArticleNature microbiology2021

The SARS-CoV-2 RNA-protein interactome in infected human cells.

Nora Schmidt, Caleb A Lareau, Hasmik Keshishian, Sabina Ganskih, Cornelius Schneider, Thomas Hennig, Randy Melanson, Simone Werner, Yuanjie Wei, Matthias Zimmer and 11 more

Open access · hybridAbstract read
In one paragraph

Article in Nature microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 218 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
218citing papers in PubMed, 3 pooled it
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

218 citing papers in PubMed, 3 syntheses or guidelines pooled it, 346 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Nonsense-mediated decay controls a negative feedback loop in innate immune sensing.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  19. Review
  20. Article

158 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 4 institutions in 2 countries.

Nora Schmidt *Helmholtz Institute for RNA-based Infection Research, Helmholtz-Center for Infection Research, Würzburg, Germany.ORCID http://orcid.org/0000-0002-3232-3491
Caleb A Lareau *School of Medicine, Stanford University, Palo Alto, CA, USA.ORCID http://orcid.org/0000-0003-4179-4807
Hasmik Keshishian *Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Sabina GanskihHelmholtz Institute for RNA-based Infection Research, Helmholtz-Center for Infection Research, Würzburg, Germany.ORCID http://orcid.org/0000-0002-1710-1014
Cornelius SchneiderInstitute for Molecular Infection Biology, University of Würzburg, Würzburg, Germany.
Thomas HennigInstitute for Virology and Immunobiology, Julius-Maximilians-University Würzburg, Würzburg, Germany.
Randy MelansonBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Simone WernerHelmholtz Institute for RNA-based Infection Research, Helmholtz-Center for Infection Research, Würzburg, Germany.
Yuanjie WeiHelmholtz Institute for RNA-based Infection Research, Helmholtz-Center for Infection Research, Würzburg, Germany.
Matthias ZimmerHelmholtz Institute for RNA-based Infection Research, Helmholtz-Center for Infection Research, Würzburg, Germany.
Jens AdeHelmholtz Institute for RNA-based Infection Research, Helmholtz-Center for Infection Research, Würzburg, Germany.ORCID http://orcid.org/0000-0003-1311-0690
Luisa KirschnerInstitute for Virology and Immunobiology, Julius-Maximilians-University Würzburg, Würzburg, Germany.
Sebastian ZielinskiHelmholtz Institute for RNA-based Infection Research, Helmholtz-Center for Infection Research, Würzburg, Germany.ORCID http://orcid.org/0000-0001-5070-1209
Lars DölkenHelmholtz Institute for RNA-based Infection Research, Helmholtz-Center for Infection Research, Würzburg, Germany.
Eric S LanderBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Neva CaliskanHelmholtz Institute for RNA-based Infection Research, Helmholtz-Center for Infection Research, Würzburg, Germany.
Utz FischerHelmholtz Institute for RNA-based Infection Research, Helmholtz-Center for Infection Research, Würzburg, Germany.
Jörg VogelHelmholtz Institute for RNA-based Infection Research, Helmholtz-Center for Infection Research, Würzburg, Germany.ORCID http://orcid.org/0000-0003-2220-1404
Steven A CarrBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Jochen BodemInstitute for Virology and Immunobiology, Julius-Maximilians-University Würzburg, Würzburg, Germany. jochen.bodem@vim.uni-wuerzburg.de.ORCID http://orcid.org/0000-0003-1908-4091
Mathias MunschauerHelmholtz Institute for RNA-based Infection Research, Helmholtz-Center for Infection Research, Würzburg, Germany. mathias.munschauer@helmholtz-hiri.de.ORCID http://orcid.org/0000-0001-6143-4548
Helmholtz Institute for RNA-based Infection Research · DEUniversity of Würzburg · DEBroad Institute · USStanford University · US

Funding

Helmholtz Association VH-NG-1428
6 · The paper itself

Abstract

Characterizing the interactions that SARS-CoV-2 viral RNAs make with host cell proteins during infection can improve our understanding of viral RNA functions and the host innate immune response. Using RNA antisense purification and mass spectrometry, we identified up to 104 human proteins that directly and specifically bind to SARS-CoV-2 RNAs in infected human cells. We integrated the SARS-CoV-2 RNA interactome with changes in proteome abundance induced by viral infection and linked interactome proteins to cellular pathways relevant to SARS-CoV-2 infections. We demonstrated by genetic perturbation that cellular nucleic acid-binding protein (CNBP) and La-related protein 1 (LARP1), two of the most strongly enriched viral RNA binders, restrict SARS-CoV-2 replication in infected cells and provide a global map of their direct RNA contact sites. Pharmacological inhibition of three other RNA interactome members, PPIA, ATP1A1, and the ARP2/3 complex, reduced viral replication in two human cell lines. The identification of host dependency factors and defence strategies as presented in this work will improve the design of targeted therapeutics against SARS-CoV-2.

Indexed as

AutoantigensCell LineCOVID-19Host-Pathogen InteractionsHumansProtein Interaction MapsProteomeRibonucleoproteinsRNA-Binding ProteinsRNA, ViralSARS-CoV-2SS-B AntigenVirus ReplicationAutoantigensCNBP protein, humanProteomeRibonucleoproteinsRNA-Binding ProteinsRNA, ViralSS-B Antigen

Identifiers

PMID33349665
PMCPMC7906908
OpenAlexW3114675079

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.